GORE EXCLUDER AAA Endoprosthesis
W. L. Gore & Associates, Inc. · Decision date Aug 20, 2025
What did the FDA decide?
FDA records P020004/S202 as a supplement to PMA P020004, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 20, 2025.
FDA approval order statement
implementation of a change in the manufacturing of the sealing cuff component of GORE EXCLUDER AAA Endoprosthesis
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 20, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P020004/S202
- Regulatory pathway
- PMA supplement
- Applicant
- W. L. Gore & Associates, Inc.
- Product code
- MIH
- Decision code
- OK30
- Decision date
- Aug 20, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- W. L. Gore & Associates, Inc.
- Product code
- MIH
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P020004/S202 received
Application receipt date recorded by FDA.
P020004/S201 · Related supplement
EXCLUDER BIFURCATED ENDOPROSTHESIS
P020004/S202 · FDA decision
30-Day Notice
P020004/S203 · Related supplement
GORE EXCLUDER Iliac Branch Endoprosthesis
P020004/S204 · Related supplement
GORE EXCLUDER AAA Endoprosthesis and Iliac Branch Endoprosthesis
P020004/S206 · Related supplement
GORE EXCLUDER AAA Endoprosthesis; GORE EXCLUDER Iliac Branch Endoprosthesis
P020004/S205 · Related supplement
GORE EXCLUDER AAA Endoprosthesis
P020004/S208 · Related supplement
GORE EXCLUDER AAA Endoprosthesis
P020004/S207 · Related supplement
GORE EXCLUDER AAA Endoprosthesis; GORE EXCLUDER Iliac Branch Endoprosthesis
Timeline entries are records held by MedtechLedger for P020004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P020004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCLUDER BIFURCATED ENDOPROSTHESISP020004/S201 | W. L. Gore & Associates, Inc. | PMA supplement | Aug 7, 2025 | FDA |
GORE EXCLUDER Iliac Branch EndoprosthesisP020004/S203 | W. L. Gore & Associates, Inc. | PMA supplement | Sep 9, 2025 | FDA |
| W. L. Gore & Associates, Inc. | PMA supplement | Oct 9, 2025 | FDA | |
| W. L. Gore & Associates, Inc. | PMA supplement | Apr 28, 2026 | FDA | |
GORE EXCLUDER AAA EndoprosthesisP020004/S205 | W. L. Gore & Associates, Inc. | PMA supplement | May 14, 2026 | FDA |
GORE EXCLUDER AAA EndoprosthesisP020004/S208 | W. L. Gore & Associates, Inc. | PMA supplement | Jun 23, 2026 | FDA |
| W. L. Gore & Associates, Inc. | PMA supplement | Jul 8, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Aug 4, 2026 | FDA | |
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA | |
| William Cook Europe Aps | PMA supplement | Aug 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
W. L. Gore & Associates, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 32360 N. N. Valley Pkwy., Phonix, AZ, 85085
Sources and methodology
- Original FDA record: P020004/S202
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





